Literature DB >> 32147816

Distinct mutational pattern of myelodysplastic syndromes with and without 5q- treated with lenalidomide.

Vera Adema1,2, Laura Palomo1, Andrea Toma3, Olivier Kosmider4, Francisco Fuster-Tormo1, Rocío Benito5,6,7, Rocío Salgado8, Esperanza Such9,10,11,12, María José Larrayoz13, Blanca Xicoy14, Jesus Maria Hernandez-Sanchez5,6,7, Paolo Maietta15, Alexander Neef9,10,11,12, Michaela Fontenay4, Mariam Ibañez9,10,11,12, Maria Diez-Campelo5,6,7, Sara Alvarez15, Jaroslaw P Maciejewski2, Pierre Fenaux4, Francesc Sole1.   

Abstract

Entities:  

Keywords:  Myelodysplastic syndromes; del(5q); lenalidomide; mutations; non-del(5q)

Mesh:

Substances:

Year:  2020        PMID: 32147816     DOI: 10.1111/bjh.16558

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  1 in total

1.  Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes.

Authors:  Leylah M Drusbosky; Christopher R Cogle
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.